Phase 3 Study of MAP0004 in Adult Migraineurs

Clinical trial NCT00623636 · COMPLETED

Trial details

NCT number: NCT00623636
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2008-07-01
Primary completion: 2010-12-01
Enrollment: 902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.